PASSAGE BIO, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2018 | — | $-12.2M | $24.9M |
| Mar 2019 | — | $-19.6M | $43.9M |
| Jun 2019 | — | $-32.9M | $78.8M |
| Sep 2019 | — | $-44.1M | $177.2M |
| Dec 2019 | — | $-56.3M | $158.9M |
| Mar 2020 | — | $386.7M | $366.8M |
| Jun 2020 | — | $363.4M | $353.4M |
| Sep 2020 | — | $338.9M | $200.6M |
| Dec 2020 | — | $304.7M | $135.0M |
| Mar 2021 | — | $441.5M | $249.5M |
| Jun 2021 | — | $402.3M | $215.5M |
| Sep 2021 | — | $362.2M | $162.9M |
| Dec 2021 | — | $318.7M | $129.0M |
| Mar 2022 | — | $281.3M | $101.6M |
| Jun 2022 | — | $248.0M | $91.1M |
| Sep 2022 | — | $224.4M | $62.6M |
| Dec 2022 | — | $201.4M | $34.6M |
| Mar 2023 | — | $170.4M | $33.4M |
| Jun 2023 | — | $150.4M | $30.3M |
| Sep 2023 | — | $126.3M | $33.6M |
| Dec 2023 | — | $111.3M | $21.7M |
| Mar 2024 | — | $104.9M | $36.8M |
| Jun 2024 | — | $90.6M | $24.8M |
| Sep 2024 | — | $72.7M | $32.3M |
| Dec 2024 | — | $61.3M | $37.6M |
| Mar 2025 | — | $46.7M | $63.4M |
| Jun 2025 | — | $38.3M | $57.6M |
| Sep 2025 | — | $31.1M | $52.8M |
| Dec 2025 | — | $18.8M | $46.3M |
| Mar 2026 | — | $11.8M | $33.3M |
| Jun 2026 | — | $4.5M | $24.2M |